In consultation: Guidance and quality standards
Showing 1 to 5 of 5
| Title | Consultation | Type | Consultation end date |
|---|---|---|---|
| Falls: assessment and prevention in older people and people 50 and over at higher risk (update) | Draft guidance consultation | NICE guideline | |
| Donanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer's disease [ID6222] | Draft guidance | Technology appraisal guidance | |
| Artificial intelligence technologies to help detect fractures on X-rays in urgent care | Diagnostics consultation | Health technology evaluation | |
| Bimekizumab for treating moderate to severe hidradenitis suppurativa [ID6134] | Draft guidance | Technology appraisal guidance | |
| Fruquintinib for previously treated metastatic colorectal cancer ID6274 | Draft guidance | Technology appraisal guidance |